Accuryn Foley Catheter Device for Atrial Tachycardia
(IAP Trial)
Trial Summary
What is the purpose of this trial?
The purpose of this study is to investigate the intra-abdominal pressure utilizing the Accuryn monitoring system during pulsed field ablation procedures in the electrophysiology lab compared to the type of anesthetic utilized.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Research Team
Karuna Rajkumar, MD
Principal Investigator
Wake Forest University Health Sciences
Eligibility Criteria
This trial is for patients with atrial tachycardia or abdominal compartment syndrome. Specific eligibility criteria are not provided, so it's important to contact the study team for details on who can participate.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo Pulsed Field Ablation (PFA) with intra-abdominal pressure monitoring using the Accuryn system
Follow-up
Participants are monitored for safety and effectiveness after the procedure, including tracking of urinary tract infections and unplanned hospital admissions
Treatment Details
Interventions
- Accuryn Foley Catheter Device
Find a Clinic Near You
Who Is Running the Clinical Trial?
Wake Forest University Health Sciences
Lead Sponsor